Mamta Kapoor-Bhushan
FDA investigator
Appears on 2 documents from 2023 to 2024, mostly at sites in Denmark. Most often cites written procedures; deviations (21 CFR 211.100).
- 2
- Documents on file
- 3.5
- Observations per 483
- 2023
- First seen
- 2024
- Most recent
What they cite most
From 7 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.68Automatic, mechanical, and electronic equipment2
- 21 CFR 211.42Design and construction features1
Activity by year
2023: 1, 2024: 1
Where
Denmark 1 · Ireland 1
Often inspects with
Is Mamta Kapoor-Bhushan coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2024-11-12 | 483 FUJIFILM Diosynth Biotechnologies Denmark ApSNov 12, 2024 · Hillerod, Denmark | Hillerod, Denmark | 3 | |
| 2023-01-24 | 483 Alexion Pharma International Operations LimitedJan 24, 2023 · Dublin, Ireland | Dublin, Ireland | 4 |
About this profile
What does Mamta Kapoor-Bhushan inspect?
Mamta Kapoor-Bhushan appears on 2 documents on file covering 2 sites, mostly in Denmark.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.22 and 21 CFR 211.68.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Mamta Kapoor-Bhushan is dated Nov 12, 2024.